Riskpilot← Back to searchSign inGet full accessMedify AB
ABActiveOrg 5590847579Holmamiralens Torg 16Computer consultancy and computer facilities management activities · NACE 6220Est. 20161 employees
Revenue 2025
SEK 204K
-40% vs 2024
EBITDA margin
12.4%
-54% vs 2024
Equity ratio
97.3%
Financial strength
Net profit 2025
SEK 24K
-55% vs 2024
| Revenue | SEK 204K | -40% |
| EBITDA | SEK 25K | -54% |
| Net profit | SEK 24K | -55% |
| Total assets | SEK 511K | -4% |
| Equity | SEK 497K | +5% |
| Employees | 1 | — |
Legal name
Medify AB
Org number
5590847579
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
11 november 2016
Share capital
SEK 55 500
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Gyllensvärd, Carl Erik Niclas H
Company purpose
Aktiebolaget skall utveckla IT-baserade system och tillhandahålla tjänster för mötesbokning samt därmed förenlig verksamhet och övrig konsultverksamhet.
Address
Holmamiralens Torg 16
Email
carl@medify.life
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 976 | 515 | 358 | 338 | 204 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | −364 | 30 | 117 | 54 | 25 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −364 | 30 | 117 | 54 | 25 |
| Net financials | −1 | −0 | −0 | −1 | −1 |
| Profit before tax | −364 | 30 | 117 | 53 | 24 |
| Tax | −0 | — | — | — | — |
| Net profit | −364 | 30 | 117 | 53 | 24 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 412 | 378 | 498 | 530 | 511 |
| Equity | 273 | 303 | 420 | 473 | 497 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 139 | 75 | 79 | 57 | 14 |
| Total debt | 139 | 75 | 79 | 57 | 14 |
EBITDA margin
12.4%
This company
15.8%
Market median
-22% vs market
20212025
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20212025
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
20212025
Net profit margin
11.8%
This company
8.1%
Market median
+46% vs market
20212025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-01-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JC Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (5) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DM/TM i Göteborg AB
Medify AB Board members of Medify AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Christer Karlsson | Chief Auditor | 0 companies |
| Carl Erik Niclas Helmuth Gyllensvärd | Board of Directors | 0 companies |
| Björn Rolf Nordenvall | Board of Directors | 0 companies |
| Carl Johan Rutger Kilander | Chairman | 0 companies |
| Erik Bäck | Board of Directors | 0 companies |
| Margaretha Suzanne Jeanette Gyllensvärd | Deputy Board Member | 0 companies |
| Ulf Johan Gunnarsson Kilander | Deputy Board Member | 0 companies |
| Sayid Sebastian Sam Zommorodi | Deputy Board Member | 0 companies |